{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:10:12Z","timestamp":1753891812229,"version":"3.41.2"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Increasing evidence has indicated that abnormal epigenetic factors such as RNA m6A modification, histone modification, DNA methylation, RNA binding proteins and transcription factors are correlated with hepatocarcinogenesis. However, it is unknown how epigenetic modification-associated genes contribute to the occurrence and clinical outcome of hepatocellular carcinoma (HCC). Thus, we constructed the epigenetic modification-associated models that may enhance the diagnosis and prognosis of HCC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study, we focused on the clinical value of epigenetic modification-associated genes for HCC. Our gene expression data were collected from TCGA and HCC data sets from the GEO database to ensure the reliability of the data. Their functions were analyzed by bioinformatics methods. We used lasso regression, Support vector machine (SVM), logistic regression and Cox regression to construct the diagnostic and prognostic models. We also constructed a nomogram of the practicability of the above-mentioned prognostic model. The above results were verified in an independent liver cancer data set from the ICGC database and clinical samples. Furthermore, we carried out pan-cancer analysis to verify the specificity of the above model and screened a wide range of drug candidates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Many epigenetic modification-associated genes were significantly different in HCC and normal liver tissues. The gene signatures showed a good ability to predict the occurrence and survival of HCC patients, as verified by DCA and ROC curve analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Gene signatures based on epigenetic modification-associated genes can be used to identify the occurrence and prognosis of liver cancer.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.649093","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T08:54:25Z","timestamp":1623920065000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Development and Validation of Epigenetic Modification-Related Signals for the Diagnosis and Prognosis of Hepatocellular Carcinoma"],"prefix":"10.3389","volume":"11","author":[{"given":"Maoqing","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianyao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diguang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronggui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuojin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00261-017-1209-1","article-title":"Epidemiology of Hepatocellular Carcinoma: Target Population for Surveillance and Diagnosis","volume":"43","author":"Tang","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.596679","article-title":"Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma","volume":"8","author":"Liu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A Global View of Hepatocellular Carcinoma: Trends, Risk, Prevention and Management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920922051","article-title":"Circulating Cytokines and Angiogenic Factors Based Signature Associated With the Relative Dose Intensity During Treatment in Patients With Advanced Hepatocellular Carcinoma Receiving Lenvatinib","volume":"12","author":"Ono","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2018.03.014","article-title":"When and How Should We Perform a Biopsy for HCC in Patients With Liver Cirrhosis in 2018","volume":"50","author":"Russo","year":"2018","journal-title":"A Rev Dig Liver Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-019-05981-0","article-title":"Diagnosis of Pre-HCC Disease by Hepatobiliary-Specific Contrast-Enhanced Magnetic Resonance Imaging: A Review","volume":"65","author":"Yang","year":"2020","journal-title":"Dig Dis Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejrad.2018.01.025","article-title":"Diagnosis and Staging of Hepatocellular Carcinoma (HCC): Current Guidelines","volume":"101","author":"Ayuso","year":"2018","journal-title":"Eur J Radiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e513","DOI":"10.1212\/WNL.0000000000011264","article-title":"Risk of Stroke in Cancer Survivors: A Meta-Analysis of Population-Based Cohort Studies","volume":"96","author":"Zhang","year":"2021","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"114285","DOI":"10.1016\/j.bcp.2020.114285","article-title":"A Nine-lncRNA Signature Predicts Distant Relapse-Free Survival of HER2-Negative Breast Cancer Patients Receiving Taxane and Anthracycline-Based Neoadjuvant Chemotherapy","volume":"189","author":"Sun","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0288-4","article-title":"The Epigenomics of Sarcoma","volume":"20","author":"Nacev","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12943-020-01197-3","article-title":"Epigenetic Regulation in Human Cancer: The Potential Role of Epi-Drug in Cancer Therapy","volume":"19","author":"Lu","year":"2020","journal-title":"Mol Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/gb-2011-12-8-r83","article-title":"Cistrome: An Integrative Platform for Transcriptional Regulation Studies","volume":"12","author":"Liu","year":"2011","journal-title":"Genome Biol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/embor.2011.233","article-title":"DNA Methylation: TET Proteins-Guardians of CpG Islands","volume":"13","author":"Williams","year":"2011","journal-title":"EMBO Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr1125","article-title":"Histome\u2013a Relational Knowledgebase of Human Histone Proteins and Histone Modifying Enzymes","volume":"40","author":"Khare","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/genes10020172","article-title":"The Roles of Human Dna Methyltransferases and Their Isoforms in Shaping the Epigenome","volume":"10","author":"Gujar","year":"2019","journal-title":"Genes (Basel)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-020-01172-y","article-title":"The Emerging Roles of N6-Methyladenosine (m6A) Deregulation in Liver Carcinogenesis","volume":"19","author":"Chen","year":"2020","journal-title":"Mol Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"baz156","DOI":"10.1093\/database\/baz156","article-title":"RBPTD: A Database of Cancer-Related RNA-Binding Proteins in Humans","volume":"2020","author":"Li","year":"2020","journal-title":"Database (Oxford)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth0208-117b","article-title":"Reannotation of Array Probes At NCBI\u2019s GEO Database","volume":"5","author":"Barrett","year":"2008","journal-title":"Nat Methods"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (GTEx) Project","volume":"45","year":"2013","journal-title":"Nat Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An Integrated Tcga Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0576-7","article-title":"Comprehensive Analysis of Chromothripsis in 2,658 Human Cancers Using Whole-Genome Sequencing","volume":"52","author":"Cort\u00e9s-Ciriano","year":"2020","journal-title":"Nat Genet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/10543400903572753","article-title":"Weighted Gene Coexpression Network Analysis: State of the Art","volume":"20","author":"Zhao","year":"2010","journal-title":"J Biopharm Stat"},{"key":"B23","doi-asserted-by":"publisher","first-page":"07TR01","DOI":"10.1088\/1361-6560\/aab4b1","article-title":"Receiver Operating Characteristic (ROC) Curves: Review of Methods With Applications in Diagnostic Medicine","volume":"63","author":"Obuchowski","year":"2018","journal-title":"Phys Med Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","article-title":"Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators","volume":"74","author":"Van Calster","year":"2018","journal-title":"Eur Urol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-0721-z","article-title":"Large-Scale Public Data Reuse to Model Immunotherapy Response and Resistance","volume":"12","author":"Fu","year":"2020","journal-title":"Genome Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"bbaa164","DOI":"10.1093\/bib\/bbaa164","article-title":"Prognosis and Personalized Treatment Prediction in TP53-Mutant Hepatocellular Carcinoma: An in Silico Strategy Towards Precision Oncology","volume":"22","author":"Yang","year":"2020","journal-title":"Brief Bioinform"},{"key":"B27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3892\/ol.2020.12095","article-title":"High Expression of TOP2A in Hepatocellular Carcinoma Is Associated With Disease Progression and Poor Prognosis","volume":"20","author":"Cai","year":"2020","journal-title":"Oncol Lett"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240319","article-title":"Inactivation of p16INK4 in Hepatocellular Carcinoma","volume":"24","author":"Hui","year":"1996","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13046-020-01667-y","article-title":"The IL1\u03b2-IL1R Signaling Is Involved in the Stimulatory Effects Triggered by Hypoxia in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs)","volume":"39","author":"Lappano","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00931","article-title":"Novel Potential Biomarkers Associated With Epithelial to Mesenchymal Transition and Bladder Cancer Prognosis Identified by Integrated Bioinformatic Analysis","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","article-title":"Targeted Therapy for Hepatocellular Carcinoma","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/ijms21030949","article-title":"Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2bpgi","volume":"21","author":"Baudi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.artmed.2017.02.001","article-title":"Analysis of Cancer-Related lncRNAs Using Gene Ontology and KEGG Pathways","volume":"76","author":"Chen","year":"2017","journal-title":"Artif Intell Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s13205-017-0850-2","article-title":"Genome Sequencing of Strain Cellulosimicrobium Sp. TH-20 With Ginseng Biotransformation Ability","volume":"7","author":"Zheng","year":"2017","journal-title":"3 Biotech"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-77","article-title":"Differential Expression of THOC1 and ALY mRNP Biogenesis\/Export Factors in Human Cancers","volume":"11","author":"Dom\u00ednguez-S\u00e1nchez","year":"2011","journal-title":"BMC Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-3965","article-title":"Sf3b2-Mediated RNA Splicing Drives Human Prostate Cancer Progression","volume":"79","author":"Kawamura","year":"2019","journal-title":"Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.21873\/cgp.20063","article-title":"Applications of Support Vector Machine (SVM) Learning in Cancer Genomics","volume":"15","author":"Huang","year":"2018","journal-title":"Cancer Genomics Proteom"},{"key":"B38","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jhep.2019.03.007","article-title":"A Comprehensive Study of Epigenetic Alterations in Hepatocellular Carcinoma Identifies Potential Therapeutic Targets","volume":"71","author":"Bayo","year":"2019","journal-title":"J Hepatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/srep33121","article-title":"Utility of the Dual-Specificity Protein Kinase TTK as a Therapeutic Target for Intrahepatic Spread of Liver Cancer","volume":"6","author":"Miao","year":"2016","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13673","article-title":"Down-Regulation of Salt-Inducible Kinase 1 (SIK1) Is Mediated by RNF2 in Hepatocarcinogenesis","volume":"8","author":"Qu","year":"2017","journal-title":"Oncotarget"},{"key":"B41","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ydbio.2011.04.028","article-title":"The Nucleolar GTP-binding Proteins Gnl2 and Nucleostemin Are Required for Retinal Neurogenesis in Developing Zebrafish","volume":"355","author":"Paridaen","year":"2011","journal-title":"Dev Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00666","article-title":"Pseudogene DUXAP8 Promotes Cell Proliferation and Migration of Hepatocellular Carcinoma by Sponging MiR-490-5p to Induce Bub1 Expression","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Genet"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102132","article-title":"Cbx3\/Hp1\u03b3 Promotes Tumor Proliferation and Predicts Poor Survival in Hepatocellular Carcinoma","volume":"11","author":"Zhong","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu097","article-title":"DYNC1H1 Mutation Alters Transport Kinetics and ERK1\/2-cFos Signalling in a Mouse Model of Distal Spinal Muscular Atrophy","volume":"137","author":"Garrett","year":"2014","journal-title":"Brain"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/s41467-020-16079-x","article-title":"Systemic Short Chain Fatty Acids Limit Antitumor Effect of CTLA-4 Blockade in Hosts With Cancer","volume":"11","author":"Coutzac","year":"2020","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.636892","article-title":"The Hypoxia-Activated Prodrug TH-302: Exploiting Hypoxia in Cancer Therapy","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/10409238.2018.1556578","article-title":"Molecular Intricacies of Aerobic Glycolysis in Cancer: Current Insights Into the Classic Metabolic Phenotype","volume":"53","author":"Ganapathy-Kanniappan","year":"2018","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31872","article-title":"Treatment of RB1-Intact Hepatocellular Carcinoma With CDK4\/6 Inhibitor Combination Therapy","author":"Sheng","year":"2021","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2018.06.004","article-title":"Exogenous Melatonin as a Treatment for Secondary Sleep Disorders: A Systematic Review and Meta-Analysis","volume":"52","author":"Li","year":"2019","journal-title":"Front Neuroendocrinol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.649093\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T13:22:25Z","timestamp":1624281745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.649093\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":49,"alternative-id":["10.3389\/fonc.2021.649093"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.649093","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2021,6,17]]},"article-number":"649093"}}